Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
•
Primary Care
When do you consider indefinite anticoagulation in someone with first episode of distal/calf vein DVT?
Does your approach in this population differ compared to proximal DVTs?
Related Questions
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen-containing vaginal ring for contraception?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
How would you manage superficial thrombophlebitis of the great saphenous vein involving the knee and calf?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
What is your approach to symptomatic superficial thrombosis of the pelvic veins occurring in the immediate postpartum period?
How would you manage superficial vein thrombosis that persists on imaging after treatment with full dose anticoagulation?
How would you counsel a female to male transgender patient regarding VTE risk with testosterone therapy, who has additional mild-moderate risk factors for thrombosis?